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The incidence of ventilator-associatedpneumonia (VAP) in pediatric patientsvaries from 5.1%-33.3% [1-3].Acinetobacter has emerged as a common
causative agent of nosocomial infections,
particularly VAP [4-6].  Originally thought to be low-
grade pathogen contaminating the hospital
environment, with its inherent ability to survive in
diverse reservoirs and develop resistance to
disinfectants and antimicrobials, it has transformed
into an emerging, multidrug-resistant nosocomial
pathogen [7].
We report an outbreak, subsequent identification
of source and control of VAP caused by carbapenem-
resistant Acinetobacter baumannii in 6 infants
admitted to the pediatric intensive care unit (PICU).
METHODS
The outbreak occurred between 18th September to
10th October 2008 at the PICU, which annually
admits over 1200 children up to 15 years of age.
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Blood cultures are obtained before initiation of
antibiotic therapy. Non-bronchoscope bronchoal-
veolar lavage (NB-BAL) is done if secondary lung
infection is suspected, the indications being
secondary fever with or without elevated white cell
count and/or C-reactive protein (CRP), new or
worsening findings on the chest X-ray, purulent
endotracheal secretions and increasing oxygen or
ventilatory requirement.
After isolating A. baumanni from clinical
specimens, a microbiologic survey for possible
sources was done. Water samples from oxygen humi-
difying chambers, ventilator humidifiers, thermo-
meter solution and swabs from ventilator tubing,
suction devices, and other surfaces were sent for
culture.
Isolates were identified biochemically and
antimicrobial susceptibility testing (AST) was done
as per Clinical and Laboratory Standards Institute
(CLSI) guidelines [8].Colony forming units per ml
(cfu/mL) were calculated and reported.
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RESULTS
During the study period there were 73 admissions to
PICU with 43(59%) children receiving ventilatory
support. Six isolates from NB-BAL grew
Acinetobacter baumannii. Relevant clinical findings
of the six infants (mean age 4.5 months) with
ventilator- associated A. baumannii pneumonia are
shown in Table I. All six received supplemental
oxygen, nebulized terbutaline, intravenous fluids
and antibiotics; five received parenteral steroids.
Initial antibiotic therapy included penicillins and
aminoglycosides followed by cefotaxime in four
infants, vancomycin in two and meropenem in four.
Three infants were directly admitted to PICU.
While one of them had arrived intubated the other
was intubated at 36 hours in PICU for respiratory
failure. The third infant improved and was
transferred out on 5th hospital day. She however
deteriorated on the 21st day with respiratory arrest,
requiring cardiopulmonary resuscitation (CPR) and
readmission to PICU.
Among those who were initially admitted to the
ward, one was intubated there for apnea and cyanosis
on the fourth day and subsequently transferred into
PICU. The other two infants were transferred to
PICU at 44 hours and seventh day for respiratory
failure and intubated shortly thereafter.
Three infants remained on ventilatory support
throughout their hospital stay. Even the three who
were extubated following apparent successful
weaning, were subsequently reintubated after a mean
49 hours (range 10-69 hours) for progressively
increasing work of breathing and fatigue.
NB- BAL done after a mean 10.3 days (range 6-
22) of hospitalization isolated multidrug-resistant
A. baumannii (>104 cfu/mL) in all six infants. X-rays
repeated simultaneously showed significant
worsening of existing infiltrates in all and evidence
of pneumonia in areas not previously affected in
four. Of two infants treated with colistin one
survived. While one infant died in the hospital, 4
were taken home terminally ill by the family.
Seven of the 12 water samples from the oxygen
humidifying chambers from the ward and the ICU
grew A. baumannii. Cultures taken from other sites
did not isolate Acinetobacter. The A. bauminii
isolates from patients and humidifiers were similar
(sensitive to colistin, and resistant to gentamicin,
amikacin, cefotaxime, ceftazidime, imipenem,
meropenem, and aztreonam).
Review of existing cleaning and maintenance of
respiratory equipments practices revealed them to be
suboptimal. New recommendations were made as
follows:  (i) daily cleaning by rinsing first with soap
solution and then plain water, (ii) air/sun drying
daily; (iii) disinfection weekly, soaking the
humidifying chamber in freshly prepared 1% sodium
hypochlorite solution for 10 minutes, ensuring that
the disinfectant completely covers and fills it,
followed by rinsing with distilled water and air/sun
drying; and (iv) usage of sterile water in the
humidifier. The outbreak was controlled with these
new practices.
TABLE I CLINICAL FINDINGS OF SIX  INFANTS WITH VENTILATOR-ASSOCIATED A.BAUMANNII PNEUMONIA
Pt Diagnosis at Place Day and place Extubation Reintu- Day NB- No of Outcome
No admission admitted of first intubation bation BALdone hospital days
1 Bronchiolitis ICU# Ward, 21 d No Day 22 25 Discharged
ASD
2 Bronchiolitis ICU ICU, 36 h No Day  8 10 Discharged*
3 WALRI,  PDA ward ICU, 7d No Day 8 10 Discharged*
4 Pneumonia ward ICU, 44h  6 d 8 d Day 6 8 Died
5 WALRI, PFO ward Ward, 4 d 6 d 6 d Day 8 21 Discharged
6 WALRI ICU arrived intubated  4 d 7 d Day 10 12 Discharged*
WALRI: wheeze associated lower respiratory tract infection; ASD: atrial septal defect; PDA: patent ductus arteriosus: PFO: patent foramen
ovale; ICU: intensive care unit; *discharged at parental request; # transferred  to ward day 5, readmitted  to ICU; BAL: Bronchoaleolar
lavage.
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DISCUSSION
Ventilator-associated, carbapenem-resistant Acineto-
bacter baumannii pneumonia was diagnosed in six
infants based on clinical and radiological findings
supported by quantitative NB-BAL cultures [9-11].
The infants had acute respiratory infections severe
enough to require ICU admission, intubation and
ventilatory support. These are exactly the known
predisposing factors [7] for Acinetobacter, which has
emerged as a significant multidrug resistant patho-
gen causing nosocomial infections, VAP in particular
[6-12] as well as line-related infections in
hospitalized oncology patients [14].
The outbreak of VAP with an organism unusual
in our ICU till then led us to an extended microbial
surveillance that revealed the same pathogen in
oxygen humidifying chambers not just in the PICU
but also the wards, where children were admitted
before and after ICU stay.
Nosocomial infection can negate the benefits of
even the best of medical care, underscoring the need
for regular surveillance for environmental
contamination with multi-drug resistant organisms
in the hospital setting. Control of the outbreak of
Acinetobacter pneumonia with humidifier
disinfection shows that simple measures of infection
control can help prevent hospital-acquired infections
in the ICU setting.
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